NCT06105372 is a clinical trial in Intermittent Fasting, sponsored by Okan University.

Who is sponsoring NCT06105372?

NCT06105372 is sponsored by Okan University.

What condition does NCT06105372 study?

NCT06105372 studies Intermittent Fasting.

Is NCT06105372 still recruiting?

NCT06105372 is currently status unknown. Last updated 27 October 2023.

Last reviewed 2023-10-27 · How we verify

NCT06105372

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ramadan Fasting, Microbiota and FABP4

Status unknown Last updated 27 October 2023

What this trial tests

trial in Intermittent Fasting in 15 participants. Status unknown.

Timeline

10 March 2023

Primary endpoint
21 April 2023

31 May 2024

Quick facts

Lead sponsor	Okan University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	15
Start date	10 March 2023
Primary completion	21 April 2023
Estimated completion	31 May 2024
Sites	1 location across Turkey (Türkiye)

Conditions studied

Intermittent Fasting — all drugs for Intermittent Fasting →

Sponsor

Okan University

Who can join

Adults 20 to 50, male only, with Intermittent Fasting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study, which aims to examine the effect of Ramadan fasting on intestinal microbiota composition and FABP4, was designed as a quasi-experimental study. This study is planned to be conducted with volunteer participants who fasted during the Ramadan and met the inclusion criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intermittent Fasting

Currently open trials in the same condition.

NCT06959069 — Impact of Intermittent Fasting on Sleep and Quality of Life · NA · recruiting
NCT06330610 — Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Vent · NA · recruiting
NCT06546033 — Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis · NA · recruiting
NCT04899102 — Intermittent Fasting for NAFLD in Adults · NA · recruiting
NCT04607096 — Intermittent Fasting to Improve Insulin Secretion · NA · recruiting

Other Okan University trials

Trials by the same sponsor.

NCT07457034 — Digital Follow-Up and Nursing Education in Bariatric Surgery Patients · NA · not yet recruiting
NCT07457905 — THE RELATIONSHIP BETWEEN PAIN ANXIETY AND POST-OPERATIVE PAIN IN PATIENTS UNDERGOING CHOLECYSTECTOMY SURGERY · not yet recruiting
NCT07462832 — Effect of Connective Tissue Massage in Low Back Pain · NA · not yet recruiting
NCT07408401 — Exercise Program Combined With Ergonomic Training in Textile Workers · NA · not yet recruiting
NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06105372 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Okan University
Last refreshed: 27 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06105372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing